# Meryx Inc.: Form D filings

Meryx Inc., a biotechnology company in Chapel Hill, NC, filed 4 Form D notices with the SEC between 2014 and 2015. The latest, on June 30, 2015, reports $2.5 million sold of a $2.5 million offering to 9 investors.

Find out what Meryx Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Meryx%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Meryx%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmeryx-inc-1606031)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Meryx%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Meryx%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmeryx-inc-1606031)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina): 984 rows, by operating companies, filed since November 1, 2024, $49.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/north-carolina
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1414 Raleigh Road, Suite 445, Chapel Hill, NC, 27517
- Phone: (919) 985-7821
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2013
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1606031

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 30, 2015 | New notice | $2,500,000 | $2,500,000 | $0 | 9 | Jun 23, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1606031/000160603115000001/0001606031-15-000001-index.htm) |
| Dec 29, 2014 | New notice | $1,544,999 | $1,544,999 | $0 | 2 | Dec 18, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1606031/000160603114000005/0001606031-14-000005-index.htm) |
| Apr 28, 2014 | Amendment | $3,100,172 | $3,100,172 | $0 | 3 | Apr 14, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1606031/000160603114000003/0001606031-14-000003-index.htm) |
| Apr 28, 2014 | New notice | $3,100,172 | $3,100,172 | $0 | 3 | Apr 14, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1606031/000160603114000001/0001606031-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Douglas K. Graham | Director |  |
| Fred K. Eshelman | Director |  |
| Seth K. Rudnick | Director |  |
| Sailash K. Patel | Executive Officer |  |
| Stephen V. Frye | Director |  |
| H. Shelton Earp | Director |  |

## Other biotechnology companies in North Carolina that filed recently

- [Toggle Bio](https://specstream.ai/data/form-d/company/toggle-bio-2158695) $200,000 · Oct 6, 2026
- [Swift Cardiovascular, Inc.](https://specstream.ai/data/form-d/company/swift-cardiovascular-inc-2117135) $810,000 · Sep 24, 2026
- [Aclarity Genomics, Inc.](https://specstream.ai/data/form-d/company/aclarity-genomics-inc-2153126) $4.6 million · Sep 2, 2026
- [Aer Therapeutics, Inc.](https://specstream.ai/data/form-d/company/aer-therapeutics-inc-1959576) $3 million · Aug 19, 2026

[Every Form D from the week of Jun 29, 2015](https://specstream.ai/data/form-d/week/2015-06-29) · [All recent filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Meryx Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).